Top Sector Life Sciences & Health (LSH) entails a broad scope of disciplines, from pharmaceuticals to medical technology and from healthcare infrastructure to vaccination. To realise its mission – vital citizens in a healthy economy - the Top Sector builds on the strengths of the Dutch LSH sector to address the biggest societal challenges in prevention, cure and care. By funding multidisciplinary public-private partnerships (PPPs) the Top Sector aims to facilitate innovation. Here we give an overview of  a number of funded R&D projects by Top Sector LSH. The page is updated continuously.

230 projects

  • The Dutch Acute Hepatitis C in HIV Study

    Multi-center research to study two new therapies for acute HCV infection (DAHHS study).
  • Muscle weakness and muscle loss: experimental models, intervention, and biomarkers

    Experimental models and biomarkers for functional decline to allow early diagnosis and efficient interventions.
  • Enhancing drug delivery to stimulate heart repair

    Hubrecht Institute and miRagen Therapeutics work together to investigate ways to better deliver new medicines to the heart.
  • Harnessing immune cells for immunoprotection in children with cardiovascular risk

    Exploring the potential of Natural Killer T-cells as a novel therapeutic target for cardiovascular disease.
  • Development of innovative, personalized cancer vaccines

    Treating and/or preventing cancer recurrence through personalized and tumor-specific DNA vaccines.
  • Bioelectronic medicines to control inflammatory biological processes and treat IBD

    Design of electrical probes for the implementation of bioelectronic medicines to control and treat inflammatory biological processes.